CClinicalTrials.gg
RecruitingNCT06920303Updated May 13, 2025

Accuracy of Transcranial Colour Coded Duplex in Comparing With CT Angiography

An observational study in Ischemic Stroke, Acute, sponsored by Sohag University. Recruiting at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2025-05-13.

Sponsored by Sohag University · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2026, 9 months ago, but the record still lists the study as recruiting.
  • Started May 2025; still recruiting 1 year 5 months later.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
100
Sex
All
01

Study summary

Investigator will compare accuracy of transcranial colour coded duplex with CT angiography in detecting arterial obstructions in patients presenting or with history of cerebrovascular ischemic strokes

Read the detailed description

Cerebrovascular stroke is one of the most common causes of death and disability in the World. It accounts for almost 5% of all disability-adjusted life-years and 10% of all deaths worldwide.

Atherosclerosis is one of the major causes of ischemic stroke, it can lead to cerebrovascular stroke through progressive stenosis, occlusion of the extra or intracranial vessels and or arterio-arterial embolization from an atheromatous plaque.

Intracranial stenosis presents with one or recurrent ischemic strokes and transient ischemic attacks.

High-grade stenosis contributes to both the occurrence and magnitude of ischemic injury.

Overall, 50% of patients have either lacunar, subcortical, or cortical infarction.

The remaining patients with intracranial stenosis have multiple lesions involving a combination of cortical, subcortical, and lacunar infarctions.

There are extensive data about carotid atherosclerosis from American, European and Asian population. However, data from Egyptian ethnics are extremely rare.

Ethnic-racial factors are related to the development of extra- and intracranial atherosclerosis.

Intracranial stenosis causes about 10% of strokes in white people, 20-29% of transient ischemic attacks or strokes in black people, and up to 40-50% of strokes in Asian people.

Extracranial atherosclerosis is common among Caucasian stroke patients. For example, in the United States and Western communities, extracranial carotid artery disease was estimated to be responsible for 20-30% of strokes, while less common in Asian and African populations.

Intracranial arterial stenosis is prevalent in the Egyptian stroke population, similar to most non-white populations.

Transcranial Doppler is routinely performed to assess the blood flow in patients with cerebral ischaemia and provides important real-time information about cerebral haemodynamics.

Transcranial doppler can aid in the diagnostic work-up by detecting, localising and grading the severity of intracranial arterial obstruction.

Transcranial Doppler is an established tool for the non-invasive assessment of cerebral blood flow. Since transcranial doppler results vary with the skills and experience of the sonographer, it requires validation against contrast angiography.

02

Conditions studied

  • Ischemic Stroke, Acute

Keywords

  • transcranial colour coded duplex
  • ct angiography
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's planned enrollment of 100 is below the median of 160 across 1,692 observational studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

one hundred cases of patients with acute ischemiac cerebrovascular stroke will be included in the study

Inclusion criteria

  • patients who have acute ischemic strokes or transient ischemic attacks .

Exclusion criteria

Exclusion Criteria:

  1. Patients with history of cardiac arrhythmia or discovered recently or known rheumatic heart disease.
  2. Patients with history of autoimmune diseases.
  3. Patients with space occupying lesion or hemorrhage in Ct brain.
  4. Pregnant female.
  5. Patients who refuse to participate in the study.
  6. Patients who have history of allergy or developed acute kidney injury during previous dye injection.
  7. Patients who have chronic kidney disease.
  8. Premorbid neurological disorder (myopathy, multiple sclerosis) on neurological examination or previous investigations.
  9. Inability to achieve safe vascular access.
  10. Patients with insufficient temporal acoustic window.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
100 participants (estimated)
Target follow-up
3 Days
Patient registry
Yes

Groups and cohorts

  • patients who suffer from ischemic cerebrovascular stroke

    All subjects must meet the following criteria to be enrolled in the study, patients who have ischemic strokes or transient ischemic attacks and will be admitted in department of neurology and psychological medicine and stroke unit at Sohag university hospital.

    Device: transcranial colour coded duplex

Interventions

  • Devicetranscranial colour coded duplex

    transcranial colour coded duplex is good non invasive tool in detect velocity and obstructions of intracranial arteries

06

What researchers measure

Primary outcomes

  1. detect accuracy of transcranial color coded duplex compared with CT angiography in diagnosing arterial obstructions in acute ischemic stroke

    investigator will detect if transcranial color coded duplex can be used for diagnosing arterial obstructions in acute ischemic stroke by measuring the peak systolic velocity of different intracranial arteries, investigator will compare with CT angiography imaging results to assess the accuracy of transcranial color coded duplex in diagnosis of acute ischemic stroke.

    Time frame: one year after enrolling one hundred cases

07

Study locations

1 of 1 sites recruiting
  • Sohag university hospital
    Sohag, Egypt
    • Magdy M Amin, professor · Contact
    Recruiting
08

References and documents

Publications

  • 1. DALYs GBD, Collaborators H. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859-922. 2. Johansson BB. Hypertension mechanisms causing stroke. Clin Exp Pharmacol Physiol. 1999;26(7):563-5.. 3. Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke. 2001;32(11):2559-66.. 4. Meseguer E, Lavallee PC, Mazighi M, et al. Yield of systematic transcranial Doppler in patients with transient ischemic attack. Ann Neurol 2010;68:9-17.

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06920303
Lead sponsor
Sohag University
Responsible party
Hassan Hamdy Hamed (Resident-neurology and psychological medicine department-Sohag hospital university, Sohag University) — Principal investigator
First posted
Apr 9, 2025
Start date
May 1, 2025
Primary completion
Jan 1, 2026 (estimated)
Completion
Sep 1, 2026 (estimated)
Last update
May 13, 2025

Study contacts

Hassan H Accuracy of Transcranial Colour Coded duplex Compared With CT, resident
Contact
hassan.hamdy@med.sohag.edu.eg
+2001060583440
Hazem K Ebrahim, professor
Contact
+2001020044243

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion